[HTML][HTML] Top 10 challenges in cancer immunotherapy

PS Hegde, DS Chen - Immunity, 2020 - cell.com
Cancer immunotherapy is a validated and critically important approach for treating patients
with cancer. Given the vast research and clinical investigation efforts dedicated to advancing …

[HTML][HTML] Current challenges and opportunities of photodynamic therapy against cancer

RV Huis in 't Veld, J Heuts, S Ma, LJ Cruz… - Pharmaceutics, 2023 - mdpi.com
BACKGROUND: Photodynamic therapy (PDT) is an established, minimally invasive
treatment for specific types of cancer. During PDT, reactive oxygen species (ROS) are …

[HTML][HTML] Human immunology and immunotherapy: main achievements and challenges

J Varadé, S Magadán… - Cellular & Molecular …, 2021 - nature.com
The immune system is a fascinating world of cells, soluble factors, interacting cells, and
tissues, all of which are interconnected. The highly complex nature of the immune system …

Immune escape mechanisms as a guide for cancer immunotherapy

GL Beatty, WL Gladney - Clinical cancer research, 2015 - AACR
Immunotherapy has demonstrated impressive outcomes for some patients with cancer.
However, selecting patients who are most likely to respond to immunotherapy remains a …

[HTML][HTML] The urgent need to recover MHC class I in cancers for effective immunotherapy

F Garrido, N Aptsiauri, EM Doorduijn, AMG Lora… - Current opinion in …, 2016 - Elsevier
Highlights•Tumor immune escape compromises the efficacy of cancer immunotherapy.•Loss
of MHC class I expression is a frequent event in cancer cells.•Three tumor phenotypes …

[HTML][HTML] Cancer vaccines, adjuvants, and delivery systems

SJ Paston, VA Brentville, P Symonds… - Frontiers in …, 2021 - frontiersin.org
Vaccination was first pioneered in the 18th century by Edward Jenner and eventually led to
the development of the smallpox vaccine and subsequently the eradication of smallpox. The …

[HTML][HTML] The role of natural killer T cells in cancer—a phenotypical and functional approach

D Krijgsman, M Hokland, PJK Kuppen - Frontiers in immunology, 2018 - frontiersin.org
Natural killer T (NKT) cells are a subset of CD1d-restricted T cells at the interface between
the innate and adaptive immune system. NKT cells can be subdivided into functional …

Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination

V Mohammadzadeh, N Rahiman, H Cabral… - Journal of Controlled …, 2023 - Elsevier
Vaccination is an innovative strategy for cancer treatment by leveraging various components
of the patients' immunity to boost an anti-tumor immune response. Rationally designed …

Cancer immune escape: MHC expression in primary tumours versus metastases

F Garrido, N Aptsiauri - Immunology, 2019 - Wiley Online Library
Tumours can escape T‐cell responses by losing major histocompatibility complex
(MHC)/human leucocyte antigen (HLA) class I molecules. In the early stages of cancer …

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

T Azuma, S Yao, G Zhu, AS Flies… - Blood, The Journal of …, 2008 - ashpublications.org
B7-H1 is an immunoglobulin-like immune suppressive molecule broadly detectable on the
majority of human and rodent cancers, and its functions have been attributed to delivering …